Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: A community study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Hoa, Nguyen Q ^a,b   Trung, Nguyen V ^c,d   Larsson, Mattias ^a   Eriksson, Bo ^e   Phuc, Ho D ^f   Chuc, Nguyen T K ^c   Lundborg, Cecilia S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Vietnam Cuba Friendship Hospital   (Viet Nam)

^c HANOI MEDICAL UNIVERSITY   (Viet Nam)

^d National Institute for Infectious and Tropical Diseases   (Viet Nam)

^e NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^f INSTITUTE OF MATHEMATICS   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PENICILLIN V; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CLINICAL EXAMINATION; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DISK DIFFUSION; DRUG USE; EPSILOMETER TEST; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; RURAL AREA; RURAL POPULATION; SOCIAL STATUS; STREPTOCOCCUS PNEUMONIAE; STRUCTURED INTERVIEW; STRUCTURED QUESTIONNAIRE; VIET NAM; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PNEUMOCOCCAL INFECTION;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; RURAL POPULATION; STREPTOCOCCUS PNEUMONIAE; VIETNAM;

EID: 77950395978     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-85     Document Type: Article

References (45)

1. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113(4):701-707. 10.1542/peds.113.4.701, 15060215.
2. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology 2005, St. Louis: Elsevier Mosby.
3. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004, 48(6):2101-2107. 10.1128/AAC.48.6.2101-2107.2004, 415617, 15155207.
4. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002, 50(Suppl):1-5.
5. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003, 52(2):229-246. 10.1093/jac/dkg321, 12865398.
6. Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Ferech M, Goosens H, Doern GV. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2007, 26(7):485-490. 10.1007/s10096-007-0321-5, 17551759.
7. Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, McGeer A, Farley MM, Vugia DJ, Lexau C, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000, 90(2):223-229. 10.2105/AJPH.90.2.223, 1446155, 10667183.
8. Tleyjeh IM, Tlaygeh HM, Hejal R, Montori VM, Baddour LM. The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis 2006, 42(6):788-797. 10.1086/500140, 16477555.
9. Goossens H, Ferech M, Stichele RV, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365(9459):579-587.
10. Larsson M, Kronvall G, Chuc NT, Karlsson I, Lager F, Hanh HD, Tomson G, Falkenberg T. Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Trop Med Int Health 2000, 5(10):711-721. 10.1046/j.1365-3156.2000.00630.x, 11044266.
11. Parry CM, Diep TS, Wain J, Hoa NT, Gainsborough M, Nga D, Davies C, Phu NH, Hien TT, White NJ, et al. Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrob Agents Chemother 2000, 44(3):484-488. 10.1128/AAC.44.3.484-488.2000, 89715, 10681307.
12. Hoa NQ, Ohman A, Lundborg CS, Chuc NT. Drug use and health-seeking behavior for childhood illness in Vietnam--a qualitative study. Health Policy 2007, 82(3):320-329. 10.1016/j.healthpol.2006.10.005, 17118482.
13. Hoa NQ, Larson M, Kim Chuc NT, Eriksson B, Trung NV, Stalsby CL. Antibiotics and paediatric acute respiratory infections in rural Vietnam: health-care providers' knowledge, practical competence and reported practice. Trop Med Int Health 2009, 14(5):546-555. 10.1111/j.1365-3156.2009.02267.x, 19320870.
14. Chuc NT, Diwan V. FilaBavi, a demographic surveillance site, an epidemiological field laboratory in Vietnam. Scand J Public Health Suppl 2003, 62:3-7. 10.1080/14034950310015031, 14578073.
15. WHO collaborating Centre for Drug Statistics Methodology Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs) 2009 2008, Oslo: WHO, WHO collaborating Centre for Drug Statistics Methodology.
16. Hanoi University of Pharmacy VN Pharmacy, the Vietnamese software for Anatomical Therapeutical Chemical Classification System with Defined Daily Dose (ATC/DDD). 2004, Hanoi: Hanoi University of Pharmacy, Hanoi University of Pharmacy.
17. Michelow IC, Lozano J, Olsen K, Goto C, Rollins NK, Ghaffar F, Rodriguez-Cerrato V, Leinonen M, McCracken GH. Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis 2002, 34(1):E1-11. 10.1086/324358, 11731965.
18. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. M100-S19. 2009, 29. Wayne, USA, Clinical and Laboratory Standards Institute (CLSI).
19. Zone breakpoints from SRGA & SRGA-M. , http://www.srga.org/
20. EUCAST clinical MIC Breakpoints. , http://www.srga.org/eucastwt/MICTAB/MICpenicillins.html
21. Trinh OT, Nguyen ND, Dibley MJ, Phongsavan P, Bauman AE. The prevalence and correlates of physical inactivity among adults in Ho Chi Minh City. BMC Public Health 2008, 8:204. 10.1186/1471-2458-8-204, 2435539, 18541020.
22. Nilsson P, Laurell MH. Carriage of penicillin-resistant Streptococcus pneumoniae by children in day-care centers during an intervention program in Malmo, Sweden. Pediatr Infect Dis J 2001, 20(12):1144-1149. 10.1097/00006454-200112000-00010, 11740321.
23. Yu S, Yao K, Shen X, Zhang W, Liu X, Yang Y. Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae among Beijing children with upper respiratory infections (2000-2005). Eur J Clin Microbiol Infect Dis 2008, 27(8):649-655. 10.1007/s10096-008-0481-y, 18347822.
24. Marchisio P, Esposito S, Schito GC, Marchese A, Cavagna R, Principi N. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine. Emerg Infect Dis 2002, 8(5):479-484. 2732490, 11996682.
25. Deeks SL, Palacio R, Ruvinsky R, Kertesz DA, Hortal M, Rossi A, Spika JS, Di Fabio JL. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics 1999, 103(2):409-413. 10.1542/peds.103.2.409, 9925833.
26. Henriques-Normark B, Blomberg C, Dagerhamn J, Battig P, Normark S. The rise and fall of bacterial clones: Streptococcus pneumoniae. Nat Rev Microbiol 2008, 6(11):827-837. 10.1038/nrmicro2011, 18923410.
27. Dinleyici EC, Yargic ZA. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era. Expert Rev Vaccines 2008, 7(9):1367-1394. 10.1586/14760584.7.9.1367, 18980540.
28. Bogaert D, Ha NT, Sluijter M, Lemmens N, De Groot R, Hermans PW. Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam. J Clin Microbiol 2002, 40(11):3903-3908. 10.1128/JCM.40.11.3903-3908.2002, 139650, 12409349.
29. Schultsz C, Vien le M, Campbell JI, Chau NV, Diep TS, Hoang NV, Nga TT, Savelkoul P, Stepnieuwska K, Parry C, et al. Changes in the nasal carriage of drug-resistant Streptococcus pneumoniae in urban and rural Vietnamese schoolchildren. Trans R Soc Trop Med Hyg 2007, 101(5):484-492. 10.1016/j.trstmh.2006.08.010, 17113613.
30. Reinert RR. Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-2001]). J Chemother 2004, 16(Suppl 6):35-48.
31. Chen R, Chen Y, Black S, Hao CL, Ding YF, Zhang T, Zhao GM. Antibiotic Resistance Patterns and Serotype Distribution in Streptococcus pneumoniae from Hospitalized Pediatric Patients with Respiratory Infections in Suzhou, China. J Trop Pediatr 2009,
32. MOH Handbook of integrated management for common childhood illness. 2006, Hanoi: Ministry of Health (MOH)- Vietnam, MOH.
33. Soriano F, Cafini F, Aguilar L, Tarrago D, Alou L, Gimenez MJ, Gracia M, Ponte MC, Leu D, Pana M, et al. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. J Antimicrob Chemother 2008, 62(6):1234-1240. 10.1093/jac/dkn392, 18799472.
34. Hoan LT, Chuc NT, Ottosson E, Allebeck P. Drug use among children under 5 with respiratory illness and/or diarrhoea in a rural district of Vietnam. Pharmacoepidemiol Drug Saf 2009, 18(6):448-453. 10.1002/pds.1730, 19326362.
35. McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, Schaffner W, Reingold A, Hadler J, Cieslak P, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003, 9(4):424-430. 10.1038/nm839, 12627227.
36. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med 2006, 119(6 Suppl 1):S3-10. 10.1016/j.amjmed.2006.03.011, 16735149.
37. Parry CM, Duong NM, Zhou J, Mai NT, Diep TS, Thinh le Q, Wain J, Van Vinh Chau N, Griffiths D, Day NP, et al. Emergence in Vietnam of Streptococcus pneumoniae resistant to multiple antimicrobial agents as a result of dissemination of the multiresistant Spain(23F)-1 clone. Antimicrob Agents Chemother 2002, 46(11):3512-3517. 10.1128/AAC.46.11.3512-3517.2002, 128725, 12384358.
38. Linares J, Ardanuy C, Pallares R, Fenoll A. Changes in antimicrobial resistance, serotypes, and genotypes in Streptococcus pneumoniae over a thirty-year period. Clin Microbiol Infect 2010,
39. Adam HJ, Hoban DJ, Gin AS, Zhanel GG. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006. Int J Antimicrob Agents 2009, 34(1):82-85. 10.1016/j.ijantimicag.2009.02.002, 19342204.
40. Vila-Corcoles A, Bejarano-Romero F, Salsench E, Ochoa-Gondar O, de Diego C, Gomez-Bertomeu F, Raga-Luria X, Cliville-Guasch X, Arija V. Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia. BMC Infect Dis 2009, 9:36. 10.1186/1471-2334-9-36, 2667188, 19320989.
41. Goossens H, Ferech M, Coenen S, Stephens P. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 2007, 44(8):1091-1095. 10.1086/512810, 17366456.
42. Grant GB, Campbell H, Dowell SF, Graham SM, Klugman KP, Mulholland EK, Steinhoff M, Weber MW, Qazi S. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis 2009, 9(3):185-196. 10.1016/S1473-3099(09)70044-1, 19246022.
43. Ginsburg CM, McCracken GH, Thomas ML, Clahsen J. Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics 1979, 64(5):627-631.
44. Sevillano D, Aguilar L, Alou L, Gimenez MJ, Gonzalez N, Echeverria O, Torrico M, Valdes L, Coronel P, Prieto J. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation. Chemotherapy 2008, 54(2):84-90. 10.1159/000118659, 18303256.
45. Schurek KN, Adam HJ, Hoban DJ, Zhanel GG. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae. Int J Antimicrob Agents 2006, 28(3):266-269. 10.1016/j.ijantimicag.2006.04.007, 16904294.